230 related articles for article (PubMed ID: 34638757)
1. Psoriasiform Inflammation Is Associated with Mitochondrial Fission/GDAP1L1 Signaling in Macrophages.
Alalaiwe A; Chen CY; Chang ZY; Sung JT; Chuang SY; Fang JY
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638757
[TBL] [Abstract][Full Text] [Related]
2. 2,4-Dimethoxy-6-Methylbenzene-1,3-diol, a Benzenoid From
Chuang SY; Chen CY; Yang SC; Alalaiwe A; Lin CH; Fang JY
Front Immunol; 2021; 12():664425. PubMed ID: 34054833
[No Abstract] [Full Text] [Related]
3. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
[TBL] [Abstract][Full Text] [Related]
4. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
5. A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice.
Griffith AD; Zaidi AK; Pietro A; Hadiono M; Yang JS; Davis R; Popkin DL
Sci Rep; 2018 Sep; 8(1):14451. PubMed ID: 30262916
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NLRP3 inflammasome-mediated pyroptosis in macrophage by cycloastragenol contributes to amelioration of imiquimod-induced psoriasis-like skin inflammation in mice.
Deng G; Chen W; Wang P; Zhan T; Zheng W; Gu Z; Wang X; Ji X; Sun Y
Int Immunopharmacol; 2019 Sep; 74():105682. PubMed ID: 31203155
[TBL] [Abstract][Full Text] [Related]
7. Salubrinal protects against inflammatory response in macrophage and attenuates psoriasiform skin inflammation by antagonizing NF-κB signaling pathway.
Shangguan Y; Chen Y; Ma Y; Zhao Y; He Y; Li W
Biochem Biophys Res Commun; 2022 Jan; 589():63-70. PubMed ID: 34891043
[TBL] [Abstract][Full Text] [Related]
8. A systematic comparison of the effect of topically applied anthraquinone aglycones to relieve psoriasiform lesion: The evaluation of percutaneous absorption and anti-inflammatory potency.
Lin CF; Chuang SY; Huang TH; Nguyen TMH; Wang PW; Alalaiwe A; Fang JY
Biomed Pharmacother; 2022 Jan; 145():112482. PubMed ID: 34915669
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells.
Xiong H; Xu Y; Tan G; Han Y; Tang Z; Xu W; Zeng F; Guo Q
Cell Physiol Biochem; 2015; 35(4):1335-46. PubMed ID: 25720416
[TBL] [Abstract][Full Text] [Related]
10. A BET inhibitor, NHWD-870, can downregulate dendritic cells maturation via the IRF7-mediated signaling pathway to ameliorate imiquimod-induced psoriasis-like murine skin inflammation.
Jin L; Dong L; Pei S; Chen X; Kuang Y; Chen W; Zhu W; Yin M
Eur J Pharmacol; 2024 Apr; 968():176382. PubMed ID: 38311277
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of punicalagin attenuates imiquimod-induced psoriasis by reducing ROS generation and inflammation via MAPK/ERK and NF-κB signaling pathways.
Wang Y; Han D; Huang Y; Dai Y; Wang Y; Liu M; Wang N; Yin T; Du W; He K; Zheng Y
Phytother Res; 2024 Feb; 38(2):713-726. PubMed ID: 38009260
[TBL] [Abstract][Full Text] [Related]
12. PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation.
Irrera N; Bitto A; Vaccaro M; Mannino F; Squadrito V; Pallio G; Arcoraci V; Minutoli L; Ieni A; Lentini M; Altavilla D; Squadrito F
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059361
[TBL] [Abstract][Full Text] [Related]
13. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway.
Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468
[TBL] [Abstract][Full Text] [Related]
14. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
15. Sinomenine Suppressed Keratinocyte Proliferation and Imiquimod-Induced Psoriasis-Like Dermatitis by Regulating lncRNA XIST.
Xiang S; Wu X; Xiang Y
Skin Pharmacol Physiol; 2022; 35(6):328-342. PubMed ID: 35960313
[TBL] [Abstract][Full Text] [Related]
16. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
17. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
[TBL] [Abstract][Full Text] [Related]
18. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
19. TLR2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation through Decrease in Regulatory T Cells and Impaired IL-10 Production.
Nakao M; Sugaya M; Fujita H; Miyagaki T; Morimura S; Shibata S; Asano Y; Sato S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202847
[TBL] [Abstract][Full Text] [Related]
20. The P2X7 receptor is not essential for development of imiquimod-induced psoriasis-like inflammation in mice.
Geraghty NJ; Mansfield KJ; Fuller SJ; Watson D; Sluyter R
Purinergic Signal; 2017 Dec; 13(4):405-415. PubMed ID: 28597172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]